Time for one-person trials

被引：725

作者：

Schork, Nicholas J. ^{[1
,2
,3
]}

机构：

[1] J Craig Venter Inst, La Jolla, CA 92037 USA

[2] Univ Calif San Diego, San Diego, CA 92103 USA

[3] Translat Genom Res Inst TGen, Phoenix, AZ USA

来源：

NATURE | 2015年 / 520卷 / 7549期

关键词：

D O I：

10.1038/520609a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Precision medicine requires a different type of clinical trial that focuses on individual, not average, responses to therapy, says Nicholas J. Schork.

引用

页码：609 / 611

页数：3

共 10 条

[1]

[Anonymous], 2016, BOX SEA PAVING WAY F

[2] Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes [J].

Chen, Rui ;

Mias, George I. ;

Li-Pook-Than, Jennifer ;

Jiang, Lihua ;

Lam, Hugo Y. K. ;

Chen, Rong ;

Miriami, Elana ;

Karczewski, Konrad J. ;

Hariharan, Manoj ;

Dewey, Frederick E. ;

Cheng, Yong ;

Clark, Michael J. ;

Im, Hogune ;

Habegger, Lukas ;

Balasubramanian, Suganthi ;

O'Huallachain, Maeve ;

Dudley, Joel T. ;

Hillenmeyer, Sara ;

Haraksingh, Rajini ;

Sharon, Donald ;

Euskirchen, Ghia ;

Lacroute, Phil ;

Bettinger, Keith ;

Boyle, Alan P. ;

Kasowski, Maya ;

Grubert, Fabian ;

Seki, Scott ;

Garcia, Marco ;

Whirl-Carrillo, Michelle ;

Gallardo, Mercedes ;

Blasco, Maria A. ;

Greenberg, Peter L. ;

Snyder, Phyllis ;

Klein, Teri E. ;

Altman, Russ B. ;

Butte, Atul J. ;

Ashley, Euan A. ;

Gerstein, Mark ;

Nadeau, Kari C. ;

Tang, Hua ;

Snyder, Michael .

CELL, 2012, 148 (06) :1293-1307

[3] Long-acting β2-agonists in asthma -: Not so SMART? [J].

Currie, Graeme P. ;

Lee, Daniel K. C. ;

Lipworth, Brian J. .

DRUG SAFETY, 2006, 29 (08) :647-656

[4] Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule [J].

Drescher, Charles W. ;

Shah, Chirag ;

Thorpe, Jason ;

O'Briant, Kathy ;

Anderson, Garnet L. ;

Berg, Christine D. ;

Urban, Nicole ;

McIntosh, Martin W. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :387-392

[5] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[6] K-ras mutations and benefit from cetuximab in advanced colorectal cancer [J].

Karapetis, Christos S. ;

Khambata-Ford, Shirin ;

Jonker, Derek J. ;

O'Callaghan, Chris J. ;

Tu, Dongsheng ;

Tebbutt, Niall C. ;

Simes, R. John ;

Chalchal, Haji ;

Shapiro, Jeremy D. ;

Robitaille, Sonia ;

Price, Timothy J. ;

Shepherd, Lois ;

Au, Heather-Jane ;

Langer, Christiane ;

Moore, Malcolm J. ;

Zalcberg, John R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1757-1765

[7]

Kravitz R, 2014, DESIGN IMPLEMENTATIO

[8] Pharmacogenomics in cardiovascular diseases [J].

Mukherjee, D ;

Topol, EJ .

PROGRESS IN CARDIOVASCULAR DISEASES, 2002, 44 (06) :479-498

[9] Using N-of-1 Trials to Improve Patient Management and Save Costs [J].

Scuffham, Paul A. ;

Nikles, Jane ;

Mitchell, Geoffrey K. ;

Yelland, Michael J. ;

Vine, Norma ;

Poulos, Christopher J. ;

Pillans, Peter I. ;

Bashford, Guy ;

del Mar, Chris ;

Schluter, Philip J. ;

Glasziou, Paul .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (09) :906-913

[10] Responder Analyses-A PhRMA Position Paper [J].

Uryniak, Tom ;

Chan, Ivan S. F. ;

Fedorov, Valerii V. ;

Jiang, Qi ;

Oppenheimer, Leonard ;

Snapinn, Steven M. ;

Teng, Chi-Hse ;

Zhang, John .

STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2011, 3 (03) :476-487

← 1 →